Virtual Medicinal Product (VMP) - Buprenorphine 74.2mg implant
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Buprenorphine 74.2mg implant | Start Date 01-04-2021 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 3 (CD No Register)
- Route
- Subcutaneous
- Form
- Prolonged-release subcutaneous implant
- Ontology Form/Route
- implant.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N07BC01
- BNF Codes
-
- BNF code 04100300
| Code | Start Date | End Date |
|---|---|---|
| 39494811000001100 | 01-04-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Buprenorphine hydrochloride | Based on Base Substance | Buprenorphine | 74.2 mg |
Name
Buprenorphine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Buprenorphine
Strength and UOM (Nmr)
74.2
Strength and UOM (Dmr)
Parent Products
-
VTMBuprenorphine
-
VMP(Current) Buprenorphine 74.2mg implant
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 4 device |